Sinopharm Group Co. Ltd.
SHTDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.61B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.61 Billion |
|---|---|
| Enterprise Value | $52.16 Billion |
| Annual dividend | $0.10 |
| Dividend yield | 5.15% |
| Earnings per Share | $2.24 |
| Beta | 0.45 |
| Outstanding Shares | 3,120,532,000 |
Return
| Return on Equity | 16.18% |
|---|---|
| Return on Assets | 3.41% |
| Return on Invested Capital | 23.49% |
Valuation & Multiples
| P/E Ratio | 5.79 |
|---|---|
| PEG | -218.74 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | 0.05 |
| Enterprise Value to EBIT | 1.52 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 1.68 |
| Debt to Equity | 1.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
$0.16
Consensus analyst estimateRevenue Estimate
$41.94 B
Consensus analyst estimateNext Earnings Call
Expected Date
March 19, 2027
EPS Estimate
$0.17
Consensus analyst estimateRevenue Estimate
$42.60 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sinopharm Group Co. Ltd.
90,447 employees
CEO: Wanyong Lian
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activ...